Search

everythinglearnresearchcommunity

for

Search:↓

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

Manipulating 5α-reductase type 2 can affect liver fat production and glucocorticoid effects.

New butyric acid prodrugs show promise for cancer treatment, anemia management, and protecting hair from chemotherapy damage.

A molecule called α-ketobutyrate was found to extend lifespan and improve aging-related symptoms in worms and mice by activating certain cellular pathways and may help develop anti-aging treatments for humans.

OXTR agonists may promote hair growth and be effective for treating hair loss.

GLP-1 receptor agonists may cause hair loss, but regrowth is rare.

Insulin resistance plays a key role in PCOS, and lifestyle changes, weight loss, and medications like metformin can help manage it.

Kelulut Honey can help regulate sex hormone receptors in rats with Polycystic Ovary Syndrome, similar to common medications.

Ezetimibe effectively reduces prostate size in cases of benign prostatic hyperplasia.

Linagliptin slows down premature aging in certain mice.

In 2024, the FDA approved 50 new drugs, including treatments for hair loss, anemia, high blood pressure, and Alzheimer's.

New compounds may soon be tested to treat excessive hair growth in women.

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

PCOS is a hormonal issue in women that is usually treated with birth control pills, metformin, and lifestyle changes, with early treatment helping to reduce complications and improve life quality.

The document concludes that managing PCOS requires a comprehensive approach, including lifestyle changes and medication, to improve symptoms and reduce health risks.

Metformin should be used for PCOS mainly in those with glucose intolerance, and has limited benefits for infertility or hirsutism.

Hormonal treatments, including birth control and antiandrogens, can effectively treat acne in women.

Young women in West Bengal, India, with PCOS often have estrogen resistance, leptin receptor issues, folate deficiency, T2DM, and acanthosis, commonly linked to obesity.

The use of Diane-35 and its generics significantly decreased in the Netherlands.

ApoBDs, once seen as waste, are now viewed as potential tools for disease treatment and tissue repair.

Men with early-onset hair loss are less responsive to bromocriptine's heart and metabolism benefits.

Medicines that lower androgen levels and hair removal treatments help manage excessive hair and acne in women with PCOS.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

Obesity is a major risk factor for insulin resistance in Taiwanese women with PCOS, which is also an independent risk factor for metabolic syndrome.

Polycystic Ovary Syndrome (PCOS) affects 6%-15% of women of reproductive age, causing symptoms like acne and hair loss, and increasing the risk of type 2 diabetes and heart disease; it's managed through diet, exercise, and medications like Metformin and hormonal contraceptives.

Spironolactone plus finasteride reduces hirsutism more effectively.

Deleting the scd1 gene in mice prevents obesity by disrupting skin lipids and improving heat regulation.

Leucine levels may affect hair loss after bariatric surgery.

Off-label drug use can be risky and requires careful consideration to ensure patient safety.